Skip to main navigation Skip to search Skip to main content

Zanubrutinib for treatment-naïve and relapsed/refractory chronic lymphocytic leukaemia: long-term follow-up of the phase I/II AU-003 study

  • Gavin Cull
  • , Jan A. Burger
  • , Stephen Opat
  • , David Gottlieb
  • , Emma Verner
  • , Judith Trotman
  • , Paula Marlton
  • , Javier Munoz
  • , Patrick Johnston
  • , David Simpson
  • , Jennifer C. Stern
  • , Radha Prathikanti
  • , Kenneth Wu
  • , William Novotny
  • , Jane Huang
  • , Constantine S. Tam

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Zanubrutinib for treatment-naïve and relapsed/refractory chronic lymphocytic leukaemia: long-term follow-up of the phase I/II AU-003 study'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science